XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 48,202 $ 49,255
Marketable securities, available for sale 54,868 33,852
Prepaid expenses and other current assets 2,253 4,857
Total current assets 105,323 87,964
Property and equipment, net 39 59
Other non-current assets 940 1,068
Total assets 106,302 89,091
Current liabilities:    
Accounts payable 2,631 507
Accrued expenses 3,295 3,638
Total current liabilities 5,926 4,145
Non-current liabilities:    
Long-term debt, net of discount 31,021 30,137
Total liabilities 36,947 34,282
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of September 30, 2024 and December 31, 2023; no shares issued or outstanding as of September 30, 2024 and December 31, 2023 0 0
Common stock, $0.0001 par value; 500,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 59,181,409 and 42,470,264 shares issued as of September 30, 2024 and December 31, 2023, respectively; 59,119,055 and 42,422,531 shares outstanding as of September 30, 2024 and December 31, 2023, respectively 6 4
Additional paid-in capital 299,343 250,825
Accumulated other comprehensive income 128 9
Treasury stock, 62,354 and 47,733 shares as of September 30, 2024 and December 31, 2023, respectively; at cost (103) (59)
Accumulated deficit (230,019) (195,970)
Total stockholders' equity 69,355 54,809
Total liabilities and stockholders' equity $ 106,302 $ 89,091